The mean baseline SBP/DBP values were 157.5 ± 18.7/89.1 ± 13.3 mmHg at the clinic, 156.9 ± 16.4/89.7 ± 12.0 mmHg at home in the morning, and 150.2 ± 17.6/85.6 ± 12.2 mmHg at

home in the evening (evening home BP). The mean pulse rates were 74.9 ± 11.2 beats/min (clinic), 72.7 ± 10.7 beats/min A 1155463 (morning home), and 72.5 ± 9.6 beats/min (evening home). The proportion of Sepantronium Poorly controlled hypertension, which was defined by both high clinic SBP and high morning home SBP, was 83.4 %, and the proportion of masked hypertension, which was defined by normal clinic SBP and high morning home SBP, was 9.9 %. During the observation period, morning home SBP was usually measured before breakfast and before dosing in a large proportion (85.2 %) of cases. Table 1 Patient characteristics at baseline (n = 4,852) Characteristic Value Gender (n [%])  Male 2,283 [47.1]  Female 2,569 [52.9] Age (years ± SD) 64.8 ± 11.9  <15 years (n [%]) 0 [0.0]  15 to <65 years (n [%]) 2,239 [46.1]  65 to <75 years (n [%]) 1,544 [31.8]  ≥75 years (n [%]) 1,060 [21.8]  Not specified (n [%]) 9 [0.2] BMI (kg/m2 ± SD) 24.28 ± 3.64  <18.5 kg/m2 (n [%]) 122 [2.5]  18.5 to <25 kg/m2 (n [%]) 1,992 [41.1]  ≥25 kg/m2 (n [%]) 1,305 [26.9]  Not calculable (n [%]) 1,433 [29.5] Diagnosis (n [%])  Essential hypertension 4,813 [99.2]  Other hypertension 39 [0.8] BP and pulse rates  Clinic beta-catenin inhibitor SBP (mmHg ± SD) 157.5 ± 18.7  Clinic DBP (mmHg ± SD)

89.1 ± 13.3  Clinic pulse rate (beats/min ± SD) 74.9 ± 11.2  Morning home SBP (mmHg ± SD) 156.9 ± 16.4  Morning home DBP (mmHg ± SD) 89.7 ± 12.0  Morning home pulse rate (beats/min ± SD) 72.7 ± 10.7  Evening home SBP (mmHg ± SD) 150.2 ± 17.6  Evening home DBP (mmHg ± SD) 85.6 ± 12.2  Evening home pulse rate (beats/min ± SD) 72.5 ± 9.6 Patient classification (n [%])  Poorly controlled hypertension Fossariinae 4,047 [83.4]  Masked hypertension 478 [9.9]  White coat hypertension 147 [3.0]  Well-controlled hypertension 180 [3.7]

Time since diagnosis (n [%])  <1 year 1,146 [23.6]  1 to <5 years 980 [20.2]  5 to <10 years 398 [8.2]  ≥10 years 1,370 [28.2]  Unknown 958 [19.7] Comorbid conditions (n [%])  Any 3,208 [66.1]  Hyperlipidemia 1,639 [33.8]  Diabetes mellitus 864 [17.8]  Heart disease 550 [11.3]  Hepatic disease 366 [7.5]  Cerebrovascular disorder 358 [7.4]  Gastrointestinal disorder 355 [7.3]  Renal disease 198 [4.1]  Respiratory disease 169 [3.5]  Malignant neoplasm 67 [1.4]  Other 851 [17.5] Previous treatment with antihypertensive drugs (n [%])  Any 2,650 [54.6]  ARB 1,775 [36.6]  Calcium antagonist 1,116 [23.0]  β-blocker 368 [7.6]  ACE inhibitor 322 [6.6]  Diuretic 289 [6.0]  α-Blocker 182 [3.8]  Other 69 [1.4] Timing of home BP measurement (n [%])  Before breakfast and before dosing 4,132 [85.2]  After breakfast and after dosing 518 [10.7]  Before breakfast and after dosing 88 [1.8]  After breakfast and before dosing 99 [2.0]  Not specified/unknown 15 [0.